Damian Alvarez-Paggi
Overview
Explore the profile of Damian Alvarez-Paggi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nurmi V, Knight C, Estcourt L, Hepojoki J, Lamikanra A, Tsang H, et al.
J Infect Dis
. 2023 Mar;
228(3):245-250.
PMID: 36967714
Convalescent plasma (CP) treatment of coronavirus disease 2019 (COVID-19) has shown significant therapeutic effect when administered early (eg, Argentinian trial showing reduced hospitalization) but has in general been ineffective (eg,...
2.
Dvorkin J, De Luca J, Alvarez-Paggi D, Caballero M
Infect Drug Resist
. 2023 Feb;
16:595-605.
PMID: 36733921
Respiratory syncytial virus (RSV) has a major role in respiratory infections in young infants around the world. However, substantial progress has been made in recent years in the field of...
3.
Hijano D, Alvarez-Paggi D, Caballero M
Front Pediatr
. 2023 Jan;
10:1114549.
PMID: 36683809
No abstract available.
4.
Caballero M, Grigaites S, De la Iglesia Niveyro P, Esperante S, Bianchi A, Nuno A, et al.
Clin Infect Dis
. 2021 Dec;
73(Suppl_5):S435-S441.
PMID: 34910178
Background: Precise determination of the causal chain that leads to community deaths in children in low- and middle-income countries is critical to estimating all causes of mortality accurately and to...
5.
Polack F, Alvarez-Paggi D, Libster R, Caballero M, Blair R, Hijano D, et al.
Sci Transl Med
. 2021 Oct;
13(616):eabj7843.
PMID: 34669442
In 1967, two toddlers immunized with a formalin-inactivated vaccine against respiratory syncytial virus (FIRSV) in the United States died from enhanced RSV disease (ERD), a severe form of illness resulting...
6.
Caballero M, Bianchi A, Grigaites S, De la Iglesia Niveyro P, Nuno A, Valle S, et al.
Clin Infect Dis
. 2021 Sep;
73(Suppl_3):S210-S217.
PMID: 34472572
Background: Many deaths in infants from low-middle income countries (LMICs) occur at home or upon arrival to health facilities. Although acute lower respiratory tract illness plays an important role in...
7.
Marc G, Alvarez-Paggi D, Polack F
J Clin Invest
. 2021 May;
131(12).
PMID: 34018969
Efforts to best protect the world from SARS-CoV-2 as variants emerge and despite limited vaccine supply are ongoing. One strategy that may maximize vaccine coverage and expedite immunization campaigns involves...
8.
Goldin C, Vazquez R, Polack F, Alvarez-Paggi D
Transl Med Commun
. 2020 Sep;
5(1):15.
PMID: 32984543
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that can affect lung physiology encompassing a wide spectrum of severities, ranging from asymptomatic and mild symptoms to severe and...
9.
Morgada M, Emiliani F, Chacon K, Alvarez-Paggi D, Murgida D, Blackburn N, et al.
Inorg Chem
. 2019 Nov;
58(23):15687-15691.
PMID: 31710470
Cu centers perform efficient long-range electron transfer. The electronic structure of native Cu sites can be described by a double-potential well with a dominant σ* ground state in fast equilibrium...
10.
Conci J, Alvarez-Paggi D, de Oliveira G, Pagani T, Esperante S, Borkosky S, et al.
Biochemistry
. 2019 Jun;
58(26):2883-2892.
PMID: 31243994
Interferon response suppression by the respiratory syncytial virus relies on two unique nonstructural proteins, NS1 and NS2, that interact with cellular partners through high-order complexes. We hypothesized that two conserved...